almotriptan


Also found in: Dictionary, Wikipedia.
Related to almotriptan: Frovatriptan, Eletriptan, sumatriptan

almotriptan

 [al″mo-trip´tan]
a selective serotonin receptor agonist used as the malate salt in the acute treatment of migraine; administered orally.

almotriptan

/al·mo·trip·tan/ (al″mo-trip´tan) a selective serotonin receptor agonist used as the malate salt in the acute treatment of migraine.

almotriptan

[al′mo-trip′tan]
a selective serotonin receptor agonist used as the malate salt in the acute treatment of a migraine; almotriptan is administered orally.

almotriptan

A selective serotonin agonist used to treat moderate to severe MIGRAINE. A brand name is Almogran.
References in periodicals archive ?
Approximately 5 years ago, Nicole was also diagnosed with chronic migraines by a local neurologist and has been taking almotriptan of 12.
She reports that she has taken four doses of almotriptan in the past 48 hours with moderate relief.
Nicole is admitted to the ICU as a precaution and immediately discontinued from taking any further fluoxetine, almotriptan, or ondansetron.
However, the recurrence rate within 48 hours after treatment was just 9% in frovatriptan-treated episodes, significantly less than the 24% rate for almotriptan (J.
Major Finding: The menstrual migraine recurrence rate 48 hours after treatment with frovatriptan was 15%, significantly less than the collective 26% rate after treatment with rizatriptan, zolmitriptan, or almotriptan.
To everyone's surprise, the higher dose of almotriptan did not reach significance for either photophobia or phonophobia," Dr.
Most recently, electriptan and almotriptan in a series of clinical trials showed a promising pharmacokinetic profile and effective outcome, but a high incidence of adverse
8,440,631, its second patent providing fast acting formulations for triptans, a class of drugs that are effective in treating migraine headaches which include sumatriptan, zolmitriptan, naratriptan, rizatriptan, eletriptan, almotriptan and frovatriptan.
market: almotriptan, naratriptan, rizatriptan, sumatriptan, and zolmitriptan.
registration of their CNS product Almotriptan for the acute treatment of migraine.
Almotriptan currently is approved in the European Union, and has been marketed in Spain since September 2000.
New products such as Pfizer's eletriptan, Pharmacia & Upjohn's almotriptan and Vanguard Medica's frovatriptan are expected to help expand the antimigraine market through 2005.